• DeutschDeutsch
  • EnglishEnglish
    • ABOUT
    • ONCOLOGY
    • PRODUCT
    • NEWS
    • INQUIRIES
    • VISIT US
ONCOSCIENCE > NEWS

ARCHIVES

  • November 2020
  • March 2019
  • October 2018
  • November 2017
  • August 2017
  • April 2016
  • July 2015
  • July 2010
  • October 2009
  • October 2008
  • April 2008
  • October 2007
  • September 2007
  • June 2007
  • September 2005
  • March 2005
  • January 2005
  • October 2004
  • August 2004
  • June 2004
  • March 2004
  • November 2003

SEARCH

  • Oncoscience AG attends the Nimotuzumab Global Scientific Meeting, 7th-10th April 2016 in Varadero/ Cuba

    Oncoscience | April 7th, 2016

    At this global clinical development meeting, more than 150 researches from over 20 countries discuss the latest results ...

  • Innokeys Pte. Ltd Consolidates Nimotuzumab Development by Acquiring Oncoscience AG

    Oncoscience | July 22nd, 2015

    The acquisition enables Innokeys to fully lead clinical and commercial development of Nimotuzumab in Europe. Transactio...

  • Oncoscience AG and GenIlac agree on cooperation terms in Turkey

    Oncoscience | July 7th, 2010

    Oncoscience, Wedel and GenIlac, Ankara agree on cooperation in Turkey for Nimotuzumab(Theraloc®), an EGFr antibody, whi...

  • Oncoscience AG presents results from Phase III study of Nimotuzumab (Theraloc®) in patients with diffuse intrinsic pontine glioma at the 41. SIOP, Sao Paulo, Brazil, October 6th-9th, 2009

    Oncoscience | October 9th, 2009

    On Friday October 9th, 2009 results from the Phase III study of the monoclonal antibody Nimotuzumab were presented. At ...

  • Funcrypta – Poster presentation at European Bioperspectives

    Oncoscience | October 4th, 2008

    Oncoscience AG is a member of the German Funcrypta project. Within the scope of this cooperation a poster will be presen...

Posts navigation

Previous 1 2 3 Next
    • LEGAL NOTICE

©Copyright of Oncoscience GmbH 2021

Diese Website benutzt Cookies. Wenn du die Website weiter nutzt, gehen wir von deinem Einverständnis aus.OKDatenschutzerklärung